Alkermes Q2 Sales $496.009M Beat $457.818M Estimate
Alkermes (NASDAQ:ALKS) reported quarterly sales of $496.009 million which beat the analyst consensus estimate of $457.818 million by 8.34 percent. This is a 26.97 percent increase over sales of $390.657 million the
Alkermes sold more products than experts predicted—about $496 million instead of the $458 million they expected. When a company beats what people guessed, it can mean their products are selling well, which is something to notice when you're watching how the company is doing.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.